跳至主要内容
临床试验/NCT05836857
NCT05836857进行中(未招募)不适用

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年1月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Cannabis (Marijuana) and CBD (Cannabidiol for Cancer Pain Survey

研究概览

简要总结

To collect information about how patients in the pain management clinic use cannabis/CBD, including how often it is used, why it is used (for example, to manage pain or other symptoms), and where patients get their information on cannabis/CBD for pain management

详细描述

Objectives

Primary Objective:

The primary objective of this study is to investigate the prevalence of current and prior cannabis and/or CBD use in cancer patients who present to the pain management clinic at MDACC.

Secondary Objectives:

The secondary objective is to investigate the reason for cannabis/CBD use (e.g. pain, neuropsychiatric symptoms, recreational or other use), degree of symptom improvement with use, frequency of use, methods of use (e.g. inhaled vs. ingested), sources of information on cannabis/CBD, and patient interest in learning more from their physicians about cannabis/CBD for cancer pain.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient or consult
  • Willing to give informed consent
  • Willing to complete the survey

排除标准

  • Refusal of informed consent
  • Refusal to complete the survey
  • Patients who previously completed the survey
  • Patients who opt-out or change their mind after agreeing to participate
  • Already an established patient at MDACC Pain Medicine Clinic
  • Patients scheduled to see Dr Abdi (PI).

研究组 & 干预措施

Cannabis (Marijuana) and Cannabidiol (CBD)

This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.

干预措施: Cannabis (Marijuana) (Behavioral)

Cannabis (Marijuana) and Cannabidiol (CBD)

This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.

干预措施: Cannabidiol (CBD) (Behavioral)

结局指标

主要结局

Cannabis (Marijuana) and CBD (Cannabidiol for Cancer Pain Survey

时间窗: through study completion; an average of 1 year.

Score scale ranges from 1-5, Extremely interested(1),Not Interested (5)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验